Alendronate and atrial fibrillation

N Engl J Med. 2007 May 3;356(18):1895-6. doi: 10.1056/NEJMc076132.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Aged
  • Alendronate / adverse effects*
  • Atrial Fibrillation / chemically induced*
  • Bone Density Conservation Agents / adverse effects*
  • Diphosphonates / adverse effects
  • Female
  • Fractures, Bone / prevention & control
  • Humans
  • Imidazoles / adverse effects
  • Osteoporosis, Postmenopausal / drug therapy
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid
  • Alendronate